NexPoint Real Estate Opportunities LLC 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-27 08:20 am Unchanged |
2023-06-27 | 13D | Paratek Pharmaceuticals, Inc. PRTK |
NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% |
0 (Unchanged) |
Filing |
| 2023-03-30 4:30 pm Purchase |
2023-03-16 | 13D | Paratek Pharmaceuticals, Inc. PRTK |
NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% |
2,822,250 (+72.92%) |
Filing |
| 2023-03-24 6:40 pm Purchase |
2023-03-16 | 13D | Paratek Pharmaceuticals, Inc. PRTK |
NexPoint Real Estate Opportunities LLC | 6,692,447 11.690% |
6,692,447 (New Position) |
Filing |
| 2023-01-20 4:15 pm Purchase |
2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
NexPoint Real Estate Opportunities LLC | 3,870,197 6.970% |
3,870,197 (New Position) |
Filing |